Antiviral Agent Lowers CMV Risk in Stem Cell Transplant – MedPage Today
MedPage Today |
Antiviral Agent Lowers CMV Risk in Stem Cell Transplant
MedPage Today The antiviral drug letermovir (Prevymis) helped prevent cytomegalovirus in patients with donor bone marrow stem cell transplantation compared with patients who received placebo, a phase III clinical trial found. A significantly smaller portion of … |
